What is the current valuation of the Transplant Diagnostics Market?

As of 2024, the Transplant Diagnostics Market was valued at 4.72 USD Billion. Read More

What is the projected market size for the Transplant Diagnostics Market by 2035?

The market is projected to reach 10.27 USD Billion by 2035. Read More

What is the expected CAGR for the Transplant Diagnostics Market during the forecast period?

The expected CAGR for the Transplant Diagnostics Market from 2025 to 2035 is 7.32%. Read More

Which segments are included in the Transplant Diagnostics Market?

The market includes segments such as Product & Service, Screening Type, and Organ Type. Read More

What were the valuations for the Instruments and Reagents & Consumables segments in 2024?

In 2024, the Instruments segment was valued at 1.89 USD Billion, while Reagents & Consumables reached 2.83 USD Billion. Read More

How does the Pre-Transplant screening type compare to Post-Transplant in terms of market size?

In 2024, the Pre-Transplant screening type was valued at 2.83 USD Billion, compared to 1.89 USD Billion for Post-Transplant. Read More

What are the market valuations for different organ types in 2024?

In 2024, the market valuations were 1.5 USD Billion for Kidney, 1.2 USD Billion for Liver, 0.8 USD Billion for Heart, 0.7 USD Billion for Lung, and 0.5 USD Billion for Pancreas. Read More

Who are the key players in the Transplant Diagnostics Market?

Key players include Thermo Fisher Scientific, Abbott Laboratories, Qiagen, Hoffmann-La Roche, and Bristol-Myers Squibb. Read More

What is the anticipated growth trend for the Transplant Diagnostics Market?

The market appears to be on a growth trajectory, with projections indicating a rise to 10.27 USD Billion by 2035. Read More

What factors might influence the growth of the Transplant Diagnostics Market?

Factors such as advancements in diagnostic technologies and increasing organ transplant procedures may influence market growth. Read More

Transplant Diagnostics Market

Transplant Diagnostics Market Research Report: Size, Share, Trend Analysis By Product & Service (Products [Instruments, Reagents & Consumables], Services), By Test Type (HLA Typing, Cross‑Matching, Donor‑Specific Antibody (DSA) Testing, Gene Expression Profiling, Biomarker Panels), By Organ Type (Kidney Transplant Diagnostics, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas / Islet Cell, Bone Marrow Transplant), By Application (Pre‑Transplant, Post‑Transplant), By End User (Hospitals & Transplant Centers, Diagnostic Laboratories, Research & Academic Institutes, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast Till 2035

Forecast Period

2026 - 2035

CAGR

7.9%

2025 Market Size

$ 8.4 Billion

2035 Market Size

$ 18 Billion

Medical Device ● Updated August 24, 2026 Report ID: MRFR/MED/0816-CR | Pages: 100 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product & Service (USD Billion)
  1. 4.1.1 Instruments
  2. 4.1.2 Reagents & Consumables
2. 4.2 Healthcare, BY Screening Type (USD Billion)
  1. 4.2.1 Pre-Transplant
  2. 4.2.2 Post-Transplant
3. 4.3 Healthcare, BY Organ Type (USD Billion)
  1. 4.3.1 Kidney
  2. 4.3.2 Liver
  3. 4.3.3 Heart
  4. 4.3.4 Lung
  5. 4.3.5 Pancreas
4. 4.4 Healthcare, BY Region (USD Billion)
  1. 4.4.1 North America
    1. 4.4.1.1 US
    2. 4.4.1.2 Canada
  2. 4.4.2 Europe
    1. 4.4.2.1 Germany
    2. 4.4.2.2 UK
    3. 4.4.2.3 France
    4. 4.4.2.4 Russia
    5. 4.4.2.5 Italy
    6. 4.4.2.6 Spain
    7. 4.4.2.7 Rest of Europe
  3. 4.4.3 APAC
    1. 4.4.3.1 China
    2. 4.4.3.2 India
    3. 4.4.3.3 Japan
    4. 4.4.3.4 South Korea
    5. 4.4.3.5 Malaysia
    6. 4.4.3.6 Thailand
    7. 4.4.3.7 Indonesia
    8. 4.4.3.8 Rest of APAC
  4. 4.4.4 South America
    1. 4.4.4.1 Brazil
    2. 4.4.4.2 Mexico
    3. 4.4.4.3 Argentina
    4. 4.4.4.4 Rest of South America
  5. 4.4.5 MEA
    1. 4.4.5.1 GCC Countries
    2. 4.4.5.2 South Africa
    3. 4.4.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott Laboratories (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Qiagen (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Hoffmann-La Roche (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bristol-Myers Squibb (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 HLA Typing (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 GenDx (NL)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Natera (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 CareDx (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY PRODUCT & SERVICE
4. 6.4 US MARKET ANALYSIS BY SCREENING TYPE
5. 6.5 US MARKET ANALYSIS BY ORGAN TYPE
6. 6.6 CANADA MARKET ANALYSIS BY PRODUCT & SERVICE
7. 6.7 CANADA MARKET ANALYSIS BY SCREENING TYPE
8. 6.8 CANADA MARKET ANALYSIS BY ORGAN TYPE
9. 6.9 EUROPE MARKET ANALYSIS
10. 6.10 GERMANY MARKET ANALYSIS BY PRODUCT & SERVICE
11. 6.11 GERMANY MARKET ANALYSIS BY SCREENING TYPE
12. 6.12 GERMANY MARKET ANALYSIS BY ORGAN TYPE
13. 6.13 UK MARKET ANALYSIS BY PRODUCT & SERVICE
14. 6.14 UK MARKET ANALYSIS BY SCREENING TYPE
15. 6.15 UK MARKET ANALYSIS BY ORGAN TYPE
16. 6.16 FRANCE MARKET ANALYSIS BY PRODUCT & SERVICE
17. 6.17 FRANCE MARKET ANALYSIS BY SCREENING TYPE
18. 6.18 FRANCE MARKET ANALYSIS BY ORGAN TYPE
19. 6.19 RUSSIA MARKET ANALYSIS BY PRODUCT & SERVICE
20. 6.20 RUSSIA MARKET ANALYSIS BY SCREENING TYPE
21. 6.21 RUSSIA MARKET ANALYSIS BY ORGAN TYPE
22. 6.22 ITALY MARKET ANALYSIS BY PRODUCT & SERVICE
23. 6.23 ITALY MARKET ANALYSIS BY SCREENING TYPE
24. 6.24 ITALY MARKET ANALYSIS BY ORGAN TYPE
25. 6.25 SPAIN MARKET ANALYSIS BY PRODUCT & SERVICE
26. 6.26 SPAIN MARKET ANALYSIS BY SCREENING TYPE
27. 6.27 SPAIN MARKET ANALYSIS BY ORGAN TYPE
28. 6.28 REST OF EUROPE MARKET ANALYSIS BY PRODUCT & SERVICE
29. 6.29 REST OF EUROPE MARKET ANALYSIS BY SCREENING TYPE
30. 6.30 REST OF EUROPE MARKET ANALYSIS BY ORGAN TYPE
31. 6.31 APAC MARKET ANALYSIS
32. 6.32 CHINA MARKET ANALYSIS BY PRODUCT & SERVICE
33. 6.33 CHINA MARKET ANALYSIS BY SCREENING TYPE
34. 6.34 CHINA MARKET ANALYSIS BY ORGAN TYPE
35. 6.35 INDIA MARKET ANALYSIS BY PRODUCT & SERVICE
36. 6.36 INDIA MARKET ANALYSIS BY SCREENING TYPE
37. 6.37 INDIA MARKET ANALYSIS BY ORGAN TYPE
38. 6.38 JAPAN MARKET ANALYSIS BY PRODUCT & SERVICE
39. 6.39 JAPAN MARKET ANALYSIS BY SCREENING TYPE
40. 6.40 JAPAN MARKET ANALYSIS BY ORGAN TYPE
41. 6.41 SOUTH KOREA MARKET ANALYSIS BY PRODUCT & SERVICE
42. 6.42 SOUTH KOREA MARKET ANALYSIS BY SCREENING TYPE
43. 6.43 SOUTH KOREA MARKET ANALYSIS BY ORGAN TYPE
44. 6.44 MALAYSIA MARKET ANALYSIS BY PRODUCT & SERVICE
45. 6.45 MALAYSIA MARKET ANALYSIS BY SCREENING TYPE
46. 6.46 MALAYSIA MARKET ANALYSIS BY ORGAN TYPE
47. 6.47 THAILAND MARKET ANALYSIS BY PRODUCT & SERVICE
48. 6.48 THAILAND MARKET ANALYSIS BY SCREENING TYPE
49. 6.49 THAILAND MARKET ANALYSIS BY ORGAN TYPE
50. 6.50 INDONESIA MARKET ANALYSIS BY PRODUCT & SERVICE
51. 6.51 INDONESIA MARKET ANALYSIS BY SCREENING TYPE
52. 6.52 INDONESIA MARKET ANALYSIS BY ORGAN TYPE
53. 6.53 REST OF APAC MARKET ANALYSIS BY PRODUCT & SERVICE
54. 6.54 REST OF APAC MARKET ANALYSIS BY SCREENING TYPE
55. 6.55 REST OF APAC MARKET ANALYSIS BY ORGAN TYPE
56. 6.56 SOUTH AMERICA MARKET ANALYSIS
57. 6.57 BRAZIL MARKET ANALYSIS BY PRODUCT & SERVICE
58. 6.58 BRAZIL MARKET ANALYSIS BY SCREENING TYPE
59. 6.59 BRAZIL MARKET ANALYSIS BY ORGAN TYPE
60. 6.60 MEXICO MARKET ANALYSIS BY PRODUCT & SERVICE
61. 6.61 MEXICO MARKET ANALYSIS BY SCREENING TYPE
62. 6.62 MEXICO MARKET ANALYSIS BY ORGAN TYPE
63. 6.63 ARGENTINA MARKET ANALYSIS BY PRODUCT & SERVICE
64. 6.64 ARGENTINA MARKET ANALYSIS BY SCREENING TYPE
65. 6.65 ARGENTINA MARKET ANALYSIS BY ORGAN TYPE
66. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT & SERVICE
67. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY SCREENING TYPE
68. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY ORGAN TYPE
69. 6.69 MEA MARKET ANALYSIS
70. 6.70 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT & SERVICE
71. 6.71 GCC COUNTRIES MARKET ANALYSIS BY SCREENING TYPE
72. 6.72 GCC COUNTRIES MARKET ANALYSIS BY ORGAN TYPE
73. 6.73 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT & SERVICE
74. 6.74 SOUTH AFRICA MARKET ANALYSIS BY SCREENING TYPE
75. 6.75 SOUTH AFRICA MARKET ANALYSIS BY ORGAN TYPE
76. 6.76 REST OF MEA MARKET ANALYSIS BY PRODUCT & SERVICE
77. 6.77 REST OF MEA MARKET ANALYSIS BY SCREENING TYPE
78. 6.78 REST OF MEA MARKET ANALYSIS BY ORGAN TYPE
79. 6.79 KEY BUYING CRITERIA OF HEALTHCARE
80. 6.80 RESEARCH PROCESS OF MRFR
81. 6.81 DRO ANALYSIS OF HEALTHCARE
82. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
83. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
84. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
85. 6.85 HEALTHCARE, BY PRODUCT & SERVICE, 2024 (% SHARE)
86. 6.86 HEALTHCARE, BY PRODUCT & SERVICE, 2024 TO 2035 (USD Billion)
87. 6.87 HEALTHCARE, BY SCREENING TYPE, 2024 (% SHARE)
88. 6.88 HEALTHCARE, BY SCREENING TYPE, 2024 TO 2035 (USD Billion)
89. 6.89 HEALTHCARE, BY ORGAN TYPE, 2024 (% SHARE)
90. 6.90 HEALTHCARE, BY ORGAN TYPE, 2024 TO 2035 (USD Billion)
91. 6.91 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.2.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.3.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.4.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.5.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.6.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.7.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.8.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.9.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.10.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.11.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.12.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.13.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.14.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.15.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.16.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.17.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.18.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.19.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.20.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.21.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.22.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.23.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.24.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.25.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.26.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.27.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.28.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.29.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY PRODUCT & SERVICE, 2025-2035 (USD Billion)
  2. 7.30.2 BY SCREENING TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY ORGAN TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Transplant diagnostics Market Segmentation

Transplant diagnostics Market By Product & Transplant diagnostics Market (USD Billion, 2025-2035)

Instruments
Reagents & Consumables

Transplant diagnostics Market By Screening Type (USD Billion, 2025-2035)

Pre-Transplant
Post-Transplant

Transplant diagnostics Market By Organ Type (USD Billion, 2025-2035)

Kidney
Liver
Heart
Lung
Pancreas

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”